Try our Advanced Search for more refined results

In Re: Ranbaxy Generic Drug Application Antitrust Litigation

  1. January 21, 2020

    Drug Buyers Say Ranbaxy Can't Have '11th Bite' At Dismissal

    Drug buyers urged a Massachusetts federal judge Friday not to let Ranbaxy seek First Circuit relief from multidistrict litigation accusing the company of gaming the generic drug approval system to gain an unfair competitive edge, arguing it's tried and failed repeatedly with the same contentions.

  2. January 02, 2020

    Ranbaxy Wants 1st Circ. To Settle Generics Antitrust Question

    Ranbaxy Inc. wants the First Circuit to take an immediate look at its bid to dismiss a multidistrict suit accusing the company of gaining an unfair edge by improperly securing approval for generic drugs, according to a New Year's Eve filing in Massachusetts federal court.

  3. April 22, 2019

    4 Firms Seek To Lead Ranbaxy Antitrust MDL In Boston

    A quartet of firms — Hagens Berman, Hilliard & Shadowen, Lowey Dannenberg and The Dugan Law Firm — hope to co-lead a multidistrict litigation in Massachusetts federal court Monday that accuses pharmaceutical company Ranbaxy of gaining an unfair competitive advantage by improperly securing approval for generic drugs.